|
|
|
Insider
Information: |
Wasman Jane |
Relationship: |
Director |
City: |
Hawthorne |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
262,961 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$195,763 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
262,961 |
|
|
Total
Value |
$195,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acorda Therapeutics Inc |
ACOR |
President, Intl and GC |
2019-12-02 |
117,420 |
|
0 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2024-05-25 |
100,000 |
2021-05-19 |
0 |
Premium* |
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
Premium* |
|
Athersys Inc (New) |
ATHX |
Director |
2023-01-09 |
35,141 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2019-12-02 |
4 |
AS |
$1.60 |
$3,553 |
D/D |
(2,227) |
117,420 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2016-09-23 |
4 |
OE |
$8.50 |
$4,250 |
D/D |
500 |
109,271 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2019-02-21 |
4 |
D |
$13.38 |
$12,751 |
D/D |
(953) |
106,834 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2016-09-23 |
4 |
AS |
$27.32 |
$13,660 |
D/D |
(500) |
108,771 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2018-11-05 |
4 |
D |
$20.28 |
$19,367 |
D/D |
(955) |
108,354 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2015-12-17 |
4 |
OE |
$6.00 |
$19,662 |
D/D |
3,277 |
112,673 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2008-06-11 |
4 |
OE |
$5.85 |
$20,475 |
D/D |
3,500 |
29,664 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2015-12-22 |
4 |
OE |
$5.85 |
$31,251 |
D/D |
5,342 |
113,921 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2015-12-21 |
4 |
AS |
$42.00 |
$34,314 |
D/D |
(817) |
108,579 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2008-12-01 |
4 |
AS |
$15.98 |
$39,950 |
D/D |
(2,500) |
23,664 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-08-10 |
4 |
AS |
$16.68 |
$41,307 |
D/D |
(2,425) |
28,139 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-11-12 |
4 |
AS |
$18.57 |
$45,551 |
D/D |
(2,425) |
20,864 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-09-26 |
4 |
AS |
$18.56 |
$45,583 |
D/D |
(2,425) |
25,714 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2008-05-12 |
4 |
AS |
$19.00 |
$46,341 |
D/D |
(2,425) |
26,164 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-10-23 |
4 |
AS |
$19.95 |
$48,813 |
D/D |
(2,425) |
23,289 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-12-21 |
4 |
AS |
$20.50 |
$49,852 |
D/D |
(2,425) |
18,439 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2008-01-23 |
4 |
AS |
$22.30 |
$55,195 |
D/D |
(2,425) |
16,014 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-02-12 |
4 |
AS |
$21.07 |
$55,746 |
D/D |
(2,600) |
33,164 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2008-02-11 |
4 |
AS |
$22.90 |
$55,767 |
D/D |
(2,425) |
13,589 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2018-03-05 |
4 |
D |
$25.95 |
$59,010 |
D/D |
(2,274) |
109,279 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2018-03-05 |
4 |
OE |
$19.81 |
$59,034 |
D/D |
2,980 |
111,553 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2015-12-23 |
4 |
OE |
$5.85 |
$62,893 |
D/D |
10,751 |
110,875 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2018-12-03 |
4 |
AS |
$20.52 |
$62,947 |
D/D |
(3,067) |
105,287 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
|
2018-03-08 |
4 |
D |
$25.65 |
$63,356 |
D/D |
(2,470) |
106,809 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec VP, General Counsel & Sec |
|
2007-05-10 |
4 |
AS |
$24.13 |
$64,414 |
D/D |
(2,600) |
30,564 |
0 |
- |
|
83 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|